Regulacje i polityka gospodarcza · 14/09/2000

National Cancer Institute Seeks Pharmaceutical or Biotechnology Partner for High-Speed Parallel Nucleic Acid Sequencing Method

The National Cancer Institute is seeking a pharmaceutical or biotechnology company to collaborate on the development of a high-speed parallel nucleic acid sequencing method, with the goal of rapid publication of research results and timely commercialization of products and treatments.